Home
About
Overview
Sharing Data
ORCID
Help
History (1)
HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy.
HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy. Gut. 2011 Feb; 60(2):261-7.
View in:
PubMed
subject areas
Aged
Amino Acid Substitution
Antiviral Agents
Drug Therapy, Combination
Female
Hepacivirus
Hepatitis C, Chronic
Humans
Interferon-alpha
Interferons
Interleukins
Male
Middle Aged
Polyethylene Glycols
Polymorphism, Single Nucleotide
Prognosis
Recombinant Proteins
Ribavirin
RNA, Viral
Treatment Outcome
Viral Load
authors with profiles
Yusuke Nakamura